Fulgent Genetics Inc
NASDAQ:FLGT
Fulgent Genetics Inc
Net Issuance of Common Stock
Fulgent Genetics Inc
Net Issuance of Common Stock Peer Comparison
Competitive Net Issuance of Common Stock Analysis
Latest Figures & CAGR of Competitors
Company | Net Issuance of Common Stock | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
Fulgent Genetics Inc
NASDAQ:FLGT
|
Net Issuance of Common Stock
-$28.8m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
DaVita Inc
NYSE:DVA
|
Net Issuance of Common Stock
-$649.9m
|
CAGR 3-Years
24%
|
CAGR 5-Years
5%
|
CAGR 10-Years
N/A
|
|
Quest Diagnostics Inc
NYSE:DGX
|
Net Issuance of Common Stock
-$216m
|
CAGR 3-Years
26%
|
CAGR 5-Years
2%
|
CAGR 10-Years
13%
|
|
CVS Health Corp
NYSE:CVS
|
Net Issuance of Common Stock
-$2.6B
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
4%
|
|
Cigna Corp
NYSE:CI
|
Net Issuance of Common Stock
-$5B
|
CAGR 3-Years
3%
|
CAGR 5-Years
-66%
|
CAGR 10-Years
-14%
|
|
Laboratory Corporation of America Holdings
NYSE:LH
|
Net Issuance of Common Stock
-$946.5m
|
CAGR 3-Years
-300%
|
CAGR 5-Years
-7%
|
CAGR 10-Years
-1%
|
See Also
What is Fulgent Genetics Inc's Net Issuance of Common Stock?
Net Issuance of Common Stock
-28.8m
USD
Based on the financial report for Mar 31, 2024, Fulgent Genetics Inc's Net Issuance of Common Stock amounts to -28.8m USD.
What is Fulgent Genetics Inc's Net Issuance of Common Stock growth rate?
Net Issuance of Common Stock CAGR 1Y
62%
Over the last year, the Net Issuance of Common Stock growth was 62%.